Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Coagulation factor X (Homo sapiens (Human)) | BDBM17283 ((2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-(4-{[(3S...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL MMDB PC cid PC sid PDB UniChem Patents Similars | PDB PubMed | n/a | n/a | 70 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | 3D Structure (crystal) | ||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041220 (1,2-bis(5-amidinobenzofuran-2-yl)ethane | 2-(2-{5-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 100 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041218 (3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-1-(1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 160 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041221 (3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 200 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041231 (3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 310 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041219 (3-(6-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-1-(1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 360 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041224 ((R)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041217 (3-(5-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 500 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041216 (2-(2-{4-[(S)-1-(1-Imino-ethyl)-pyrrolidin-3-yloxy]...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 640 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041223 (3-(6-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 840 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041215 (2-{2-[4-((S)-Pyrrolidin-3-yloxy)-phenyl]-ethyl}-be...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 940 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041222 (3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041226 (3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.50E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041227 (3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041214 (3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 1.70E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041216 (2-(2-{4-[(S)-1-(1-Imino-ethyl)-pyrrolidin-3-yloxy]...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 4.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041225 (3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 4.10E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041228 (3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 4.20E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041220 (1,2-bis(5-amidinobenzofuran-2-yl)ethane | 2-(2-{5-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041229 (2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 9.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041217 (3-(5-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041230 (2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.00E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041222 (3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.10E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041219 (3-(6-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-1-(1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041214 (3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 3.60E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041228 (3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 3.80E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041229 (2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 4.50E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Coagulation factor X (Homo sapiens (Human)) | BDBM50041230 (2-(5-Carbamimidoyl-benzofuran-2-yl)-3-[4-((S)-pyrr...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 5.20E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting factor Xa by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041225 (3-(6-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | >1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041215 (2-{2-[4-((S)-Pyrrolidin-3-yloxy)-phenyl]-ethyl}-be...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | 1.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041226 (3-(5-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | 2.30E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041223 (3-(6-Carbamimidoyl-benzofuran-2-yl)-2-{4-[(S)-1-(1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | >4.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041231 (3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | >6.00E+5 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041224 ((R)-3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041227 (3-(6-Carbamimidoyl-benzofuran-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | PubMed | n/a | n/a | >1.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041218 (3-(7-Carbamimidoyl-naphthalen-2-yl)-2-{4-[(S)-1-(1...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | >1.20E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM50041221 (3-(7-Carbamimidoyl-naphthalen-2-yl)-2-[4-((S)-pyrr...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Patents Similars | PubMed | n/a | n/a | >1.60E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Prothrombin (Homo sapiens (Human)) | BDBM17283 ((2S)-3-(7-carbamimidoylnaphthalen-2-yl)-2-(4-{[(3S...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | CHEMBL MMDB PC cid PC sid PDB UniChem Patents Similars | PubMed | n/a | n/a | >2.00E+6 | n/a | n/a | n/a | n/a | n/a | n/a |
Daiichi Pharmaceutical Company, Ltd. Curated by ChEMBL | Assay Description In vitro evaluation for the concentration needed for inhibiting thrombin by 50% | J Med Chem 37: 1200-7 (1994) BindingDB Entry DOI: 10.7270/Q2FF3RF6 | |||||||||||
More data for this Ligand-Target Pair |